A round of thanks is clearly owed to retail investors, who have been faithfully buying the dip as institutional investors and hedge funds shied away. Not everyone is enthusiastic, though.

He spotted the opportunity to invest in weight-loss drugs in 2023 before they exploded in 2024, and was an early AI mover, which he spied as a game changer in late 2022, early 2023. It's all about ...